These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7526756)

  • 1. Immunostimulation in sepsis.
    Percopo V; Taddeo F; Cobellis L; Tesauro B
    Ann Ital Chir; 1994; 65(1):45-7; discussion 48. PubMed ID: 7526756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment with immunomodulating drugs of patients with operated cancer. Long-term results].
    Sortini A; Di Marco L; Navarra G; Donini A; Fiorentini G; Santini M; Sartori A; Donini I
    Minerva Chir; 1994 Nov; 49(11):1101-5. PubMed ID: 7708231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The possibility of the restoration of interferon formation by biologically active thymus factors in experimentally induced immunodepression].
    Chernenko OD; Grinevich IuA
    Vopr Virusol; 1991; 36(4):309-10. PubMed ID: 1724585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunostimulation and host resistance against infection: therapeutic perspectives.
    Fauve RM
    Adv Nephrol Necker Hosp; 1980; 9():167-86. PubMed ID: 6157316
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoprophylaxis with thymostimulin in oncological surgery.
    Russello D; Puleo S; Succi L; Di Cataldo A; Scuideri M; Scilletta B; Di Blasi M; Guastella T; Latteri F
    J Chemother; 1989 Jul; 1(4 Suppl):1307-8. PubMed ID: 16312878
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunostimulants].
    Lesavre P; Bach JF
    Rev Prat; 1980 Mar; 30(15):907-8, 911-5. PubMed ID: 6154961
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunotherapy of sepsis: myth or reality?].
    Vinnitskiĭ LI; Vitvitskaia IM; Popov OIu
    Anesteziol Reanimatol; 1997; (3):89-97. PubMed ID: 9290000
    [No Abstract]   [Full Text] [Related]  

  • 8. [Characteristics and clinical use of immunostimulants].
    Shirinskiĭ VS; Zhuk EA
    Ter Arkh; 1990; 62(12):125-32. PubMed ID: 1707558
    [No Abstract]   [Full Text] [Related]  

  • 9. [New therapeutic possibilities in acute and chronic viral hepatitis].
    Kiczka W
    Przegl Epidemiol; 1979; 33(2):217-25. PubMed ID: 482640
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunocorrection in the treatment of diffuse peritonitis in aged patients].
    Briskin BS; Khachatrian NN; Peters GE; Kasat'ian GS; Fesenko TA
    Khirurgiia (Mosk); 2008; (10):19-26. PubMed ID: 19008810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymostimulin effect on the immune response in neoplastic patients submitted to surgical treatment.
    Cangemi V; Volpino P; D'Andrea N; Gentili S; Fabrizi S; Ippoliti F; Piat G
    Panminerva Med; 1993 Dec; 35(4):218-23. PubMed ID: 8202335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunostimulants and infectious diseases].
    Grob PJ; Fontana A
    Ther Umsch; 1982 Sep; 39(9):668-74. PubMed ID: 6184840
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ways of correcting immunodeficiency at different stages of burns with the aim of prevention and treatment of sepsis].
    Nazarov IP; Popov AA; Protopopov BV; Kokoulina ZhN
    Anesteziol Reanimatol; 1999; (1):63-8. PubMed ID: 10199053
    [No Abstract]   [Full Text] [Related]  

  • 14. Thymostimulin effect on the immune response in pulmonary carcinoma with or without surgical treatment.
    Cangemi V; Volpino P; D'Andrea N; Gentili S; Salsano F; Rivi R; Ippoliti F; Piat G
    Panminerva Med; 1993 Dec; 35(4):224-30. PubMed ID: 8202336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The dangers of evidence-based medicine].
    Raffy O
    Rev Prat; 1999 Apr; 49(8):801-2. PubMed ID: 10337188
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of immunomocorrection in the combined treatment of laryngeal papillomatosis in children].
    Savenko IV; Tsvetkov EA
    Vestn Otorinolaringol; 1996; (4):12-4. PubMed ID: 8966869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic immunopharmacology.
    Hadden JW
    Curr Opin Immunol; 1989 Dec; 2(2):258-63. PubMed ID: 2483056
    [No Abstract]   [Full Text] [Related]  

  • 18. [The typological characteristics of the stress activation of lipid peroxidation and its correction by thymopentin].
    Tarasenko LM; Neporada KS; Skrypnyk IM; Klusha VIe
    Fiziol Zh (1994); 1997; 43(1-2):113-6. PubMed ID: 9221111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of a new approach to the pathogenetic therapy of oncological patients].
    Mkrtchian LN; Shukurian SG; Kamalian LA; Aleksanian KA; Ambartsumian AM
    Eksp Onkol; 1990; 12(1):13-5. PubMed ID: 1688762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunomodulators and chemical preparations in the therapy of the acquired immunodeficiency syndrome].
    Zhdanov VM; Barinskiĭ IF; Ershov FI; Nesterchuk SL
    Vopr Virusol; 1987; 32(1):6-14. PubMed ID: 2437706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.